| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ... New England journal of medicine 369 (18), 1691-1703, 2013 | 7164 | 2013 |
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical … MJ Moore, D Goldstein, J Hamm, A Figer, JR Hecht, S Gallinger, HJ Au, ... Journal of clinical oncology 25 (15), 1960-1966, 2007 | 4953 | 2007 |
| Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JP Neoptolemos, DD Stocken, C Bassi, P Ghaneh, D Cunningham, ... Jama 304 (10), 1073-1081, 2010 | 1689 | 2010 |
| Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib … P Hammel, F Huguet, JL van Laethem, D Goldstein, B Glimelius, P Artru, ... Jama 315 (17), 1844-1853, 2016 | 1113 | 2016 |
| Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation … SY Ngan, B Burmeister, RJ Fisher, M Solomon, D Goldstein, D Joseph, ... Journal of clinical oncology 30 (31), 3827-3833, 2012 | 1070 | 2012 |
| Chemotherapy‐induced peripheral neurotoxicity: a critical analysis SB Park, D Goldstein, AV Krishnan, CSY Lin, ML Friedlander, J Cassidy, ... CA: a cancer journal for clinicians 63 (6), 419-437, 2013 | 852 | 2013 |
| Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells MV Apte, S Park, PA Phillips, N Santucci, D Goldstein, RK Kumar, ... Pancreas 29 (3), 179-187, 2004 | 768 | 2004 |
| nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial D Goldstein, RH El-Maraghi, P Hammel, V Heinemann, V Kunzmann, ... Journal of the National Cancer Institute 107 (2), dju413, 2015 | 738 | 2015 |
| Pancreatic stellate cells: partners in crime with pancreatic cancer cells A Vonlaufen, S Joshi, C Qu, PA Phillips, Z Xu, NR Parker, CS Toi, ... Cancer research 68 (7), 2085-2093, 2008 | 608 | 2008 |
| Cancer patient preferences for communication of prognosis in the metastatic setting RG Hagerty, PN Butow, PA Ellis, EA Lobb, S Pendlebury, N Leighl, ... Journal of clinical oncology 22 (9), 1721-1730, 2004 | 597 | 2004 |
| Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study JW Valle, D Palmer, R Jackson, T Cox, JP Neoptolemos, P Ghaneh, ... Journal of clinical oncology 32 (6), 504-512, 2014 | 486 | 2014 |
| Role of pancreatic stellate cells in pancreatic cancer metastasis Z Xu, A Vonlaufen, PA Phillips, E Fiala-Beer, X Zhang, L Yang, AV Biankin, ... The American journal of pathology 177 (5), 2585-2596, 2010 | 442 | 2010 |
| Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and … M Van Glabbeke, J Verweij, PG Casali, A Le Cesne, P Hohenberger, ... Journal of Clinical Oncology 23 (24), 5795-5804, 2005 | 367 | 2005 |
| Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study J Tie, JD Cohen, Y Wang, L Li, M Christie, K Simons, H Elsaleh, ... Gut 68 (4), 663-671, 2019 | 341 | 2019 |
| Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer B Thewes, B Meiser, A Taylor, KA Phillips, S Pendlebury, A Capp, ... Journal of Clinical Oncology 23 (22), 5155-5165, 2005 | 335 | 2005 |
| Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial W Greenhalf, P Ghaneh, JP Neoptolemos, DH Palmer, TF Cox, RF Lamb, ... Journal of the National Cancer Institute 106 (1), djt347, 2014 | 311 | 2014 |
| Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review BK Clifford, D Mizrahi, CX Sandler, BK Barry, D Simar, CE Wakefield, ... Supportive care in cancer 26, 685-700, 2018 | 296 | 2018 |
| Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer D Yip, C Karapetis, A Strickland, CB Steer, D Goldstein Cochrane database of systematic reviews, 2006 | 292 | 2006 |
| Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies SB Park, AV Krishnan, CSY Lin, D Goldstein, M Friedlander, MC Kiernan Current medicinal chemistry 15 (29), 3081-3094, 2008 | 278 | 2008 |
| Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer JF Bishop, J Dewar, GC Toner, J Smith, MHN Tattersall, IN Olver, ... Journal of Clinical Oncology 17 (8), 2355-2355, 1999 | 271 | 1999 |
